Undergraduate - UnitBTH3012 - Biotechnology science, industry and commercialisation

This unit entry is for students who completed this unit in 2014 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

Level	Undergraduate
Faculty	Faculty of Science
Offered	Clayton Second semester 2014 (Day)
Coordinator(s)	Professor Michael Vitale and Dr Lynne Mayne (deputy co-ordinator)

Synopsis

This unit will examine case studies of biotechnology research and development and will consider the industry context in which biotechnology is commercialised including: industry structure; methods of financing, management approaches; and product development.

Outcomes

On completion of this unit students will be able to:

Describe the structure of the biotechnology industry, both in Australia and globally;

Describe the pathways from discovery science that lead to innovation and commercialisation of biotechnology innovations;

Explain the critical role of intellectual property in the commercialisation of biotechnology;

Assess the potential for commercial development of a specific biotechnology innovation;

Systematically build and validate academic arguments by critically deconstructing relevant published research, working both independently and as part of a team;

Demonstrate an approach to learning and professional development based on self-evaluation and personal responsibility.

Assessment

Essay (3000 words): 40%
Tutorial reports (including class presentations) (4 x 750 words): 40%
Oral presentation and written report (1000 words): 20%

Chief examiner(s)

Dr Lynne Mayne

Workload requirements

Two 1-hour lectures and one 2-hour tutorial per week

Prerequisites

BTH2012